Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lyn S Pilowsky

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Expert Review of Neurotherapeutics|October 9, 2009
New targets for antipsychoticsHugh M Jones, Lyn S Pilowsky
European Psychiatry : the Journal of the Association of European Psychiatrists|March 21, 2006
The contribution of brain imaging to understanding the mechanism of second generation antipsychotic drugsLyn S Pilowsky, James M Stone
Expert Review of Neurotherapeutics|February 10, 2006
Antipsychotic drug action: targets for drug discovery with neurochemical imagingJames M Stone, Lyn S Pilowsky
Expert Review of Neurotherapeutics|December 26, 2006
Schizophrenia: more evidence for less glutamatePaul D Morrison, Lyn S Pilowsky
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|September 17, 2003
[Glutamatergic hypothesis of schizophrenia]Rodrigo A Bressan, Lyn S Pilowsky
The American Journal of Psychiatry|February 2, 2002
Clozapine and dopamine D(2) blockadeLyn S Pilowsky, Peter J Ell
Journal of Psychopharmacology (Oxford, England)|January 30, 2007
Glutamate and dopamine dysregulation in schizophrenia--a synthesis and selective reviewJames M Stone, Paul D Morrison, Lyn S Pilowsky
Journal of Psychopharmacology (Oxford, England)|April 27, 2004
Atypical antipsychotic drugs and tardive dyskinesia: relevance of D2 receptor affinityRodrigo A Bressan, Hugh M Jones, Lyn S Pilowsky
Neuropsychology|September 29, 2005
Hallucinations, negative symptoms, and response bias in a verbal recognition task in schizophreniaGildas Brébion, Anthony S David, Hugh Jones, et al.
Neuropsychology|April 22, 2004
Semantic organization and verbal memory efficiency in patients with schizophreniaGildas Brébion, Anthony S David, Hugh Jones, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Expert Review of Neurotherapeutics|October 9, 2009
New targets for antipsychoticsHugh M Jones, Lyn S Pilowsky
European Psychiatry : the Journal of the Association of European Psychiatrists|March 21, 2006
The contribution of brain imaging to understanding the mechanism of second generation antipsychotic drugsLyn S Pilowsky, James M Stone
Expert Review of Neurotherapeutics|February 10, 2006
Antipsychotic drug action: targets for drug discovery with neurochemical imagingJames M Stone, Lyn S Pilowsky
Expert Review of Neurotherapeutics|December 26, 2006
Schizophrenia: more evidence for less glutamatePaul D Morrison, Lyn S Pilowsky
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|September 17, 2003
[Glutamatergic hypothesis of schizophrenia]Rodrigo A Bressan, Lyn S Pilowsky
The American Journal of Psychiatry|February 2, 2002
Clozapine and dopamine D(2) blockadeLyn S Pilowsky, Peter J Ell
Journal of Psychopharmacology (Oxford, England)|January 30, 2007
Glutamate and dopamine dysregulation in schizophrenia--a synthesis and selective reviewJames M Stone, Paul D Morrison, Lyn S Pilowsky
Journal of Psychopharmacology (Oxford, England)|April 27, 2004
Atypical antipsychotic drugs and tardive dyskinesia: relevance of D2 receptor affinityRodrigo A Bressan, Hugh M Jones, Lyn S Pilowsky
Neuropsychology|September 29, 2005
Hallucinations, negative symptoms, and response bias in a verbal recognition task in schizophreniaGildas Brébion, Anthony S David, Hugh Jones, et al.
Neuropsychology|April 22, 2004
Semantic organization and verbal memory efficiency in patients with schizophreniaGildas Brébion, Anthony S David, Hugh Jones, et al.
Pageof 6